Tabectedin to Treat Children and Adolescents With Cancer
NCT01453283
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
NIH
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Trabectedin (ecteinascidin-743, ET-743, YONDELIS [R])
Sponsor
National Cancer Institute (NCI)